BostonGene and Kyoto University link on oesophageal cancer drug
The research expands upon the investigator-initiated Phase II Nobel clinical study led by Dr Manabu Muto of Kyoto University.
Drug Development
AHA 2025: Gene therapy shows potential in chronic heart failure
Harbour BioMed and Evinova collaborate on AI biologics
Pelthos acquires US rights to Xepi cream from Biofrontera and Ferrer
SanegeneBio and Lilly sign RNAi licence deal for metabolic diseases
Abzena and Mabqi partner for drug development solution
Cencora to invest $1bn in US pharma distribution network
Leukogene Therapeutics gains FDA ODD status for M2T-CD33
